# THE-0504 in Patients With Solid Tumors

> **NCT07646106** · PHASE1 · RECRUITING · sponsor: **Thena Biotech S.r.l.** · enrollment: 30 (estimated)

## Conditions studied

- Small Cell Lung Cancer (SCLC)
- Colorectal Carcinoma (CRC)
- Gastric Cancer (GC)
- Triple -Negative Breast Cancer
- Pancreas Adenocarcinoma

## Interventions

- **DRUG:** THE-0504

## Key facts

- **NCT ID:** NCT07646106
- **Lead sponsor:** Thena Biotech S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-13
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646106, "THE-0504 in Patients With Solid Tumors". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07646106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*